U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hyperextensibility at elbow

MedGen UID:
869381
Concept ID:
C4023808
Anatomical Abnormality
HPO: HP:0010485

Definition

The ability of the elbow joint to move beyond its normal range of motion. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Hyperextensibility at elbow

Conditions with this feature

Ehlers-Danlos syndrome, classic type, 1
MedGen UID:
78660
Concept ID:
C0268335
Disease or Syndrome
Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.
Deficiency of hyaluronoglucosaminidase
MedGen UID:
226942
Concept ID:
C1291490
Disease or Syndrome
Mucopolysaccharidosis type IX (MPS9) is a rare progressive lysosomal storage disorder caused by the deficiency of the enzyme hyaluronoglucosaminidase-1, which degrades hyaluronan (summary by Imundo et al., 2011).
Osteogenesis imperfecta type 5
MedGen UID:
419332
Concept ID:
C2931093
Disease or Syndrome
Osteogenesis imperfecta (OI) is a connective tissue disorder characterized by bone fragility and low bone mass. Due to considerable phenotypic variability, Sillence et al. (1979) developed a classification of OI subtypes based on clinical features and disease severity: OI type I, with blue sclerae (166200); perinatal lethal OI type II, also known as congenital OI (166210); OI type III, a progressively deforming form with normal sclerae (259420); and OI type IV, with normal sclerae (166220). Most forms of OI are autosomal dominant with mutations in one of the 2 genes that code for type I collagen alpha chains, COL1A1 (120150) and COL1A2 (120160). Glorieux et al. (2000) described a novel autosomal dominant form of OI, which they designated OI type V (OI5), in 7 patients. The disorder was similar to OI type IV but had distinctive clinical, histologic, and molecular characteristics. OI type V is characterized by calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation (summary by Cho et al., 2012). OI type V has a variable phenotype. For example, in patients with the more common c.-14C-T variant (614757.0001), distinctive radiographic findings (calcification of the forearm interosseous membrane, radial head dislocation, a subphyseal metaphyseal radiodense line, and hyperplastic callus formation) are often seen, whereas these findings are not seen in patients with the less common S40L variant (614757.0002).
Cerebellar dysfunction with variable cognitive and behavioral abnormalities
MedGen UID:
766575
Concept ID:
C3553661
Disease or Syndrome
Cerebellar dysfunction with variable cognitive and behavioral abnormalities (CECBA) is an autosomal dominant neurologic disorder with significant phenotypic heterogeneity, even within families. The disorder is most often diagnosed through genetic analysis with retrospective clinical phenotyping. Symptom onset is usually in early childhood, although later onset, even in adulthood, has been reported. Most affected individuals show global developmental delay from early childhood, particularly of motor and language skills. Many have mild intellectual disability; behavioral and psychiatric abnormalities such as autism and obsessive-compulsive disorder are also often observed. The movement disorder is prominent and may include cerebellar signs such as ataxia, tremor, dysmetria, poor coordination, and dysarthria. Other abnormal movements including spasticity, myoclonus, and dystonia have been reported, thus widening the phenotypic spectrum. Brain imaging is usually normal, but may show cerebellar atrophy or nonspecific white matter lesions. Variable dysmorphic facial features may also be present (summary by Thevenon et al., 2012; Jacobs et al., 2021; Wijnen et al., 2020).

Recent clinical studies

Etiology

Abihssira S, Benistan K, Nourissat G
Orphanet J Rare Dis 2024 Sep 23;19(1):351. doi: 10.1186/s13023-024-03261-3. PMID: 39313806Free PMC Article
Colombi M, Dordoni C, Venturini M, Ciaccio C, Morlino S, Chiarelli N, Zanca A, Calzavara-Pinton P, Zoppi N, Castori M, Ritelli M
Clin Genet 2017 Dec;92(6):624-631. Epub 2017 Sep 4 doi: 10.1111/cge.13052. PMID: 28485813
Chang KY, Tho KS, Khong KS
Ann Acad Med Singap 1997 Jul;26(4):453-5. PMID: 9395809

Diagnosis

Bishnoi A, Jamwal M, Das R, Scaria V, Vishwajeet V, De D, Saikia UN, Mahajan R
Am J Med Genet A 2021 Jan;185(1):278-281. Epub 2020 Oct 27 doi: 10.1002/ajmg.a.61943. PMID: 33111394
Ni X, Jin C, Jiang Y, Wang O, Li M, Xing X, Xia W
BMC Med Genet 2020 Oct 31;21(1):214. doi: 10.1186/s12881-020-01154-3. PMID: 33129265Free PMC Article
Tug E, Ergun MA, Percin EF
Genet Couns 2016;27(4):471-478. PMID: 30226965
Kasnauskiene J, Ciuladaite Z, Preiksaitiene E, Matulevičienė A, Alexandrou A, Koumbaris G, Sismani C, Pepalytė I, Patsalis PC, Kučinskas V
Eur J Med Genet 2012 Apr;55(4):274-7. Epub 2012 Mar 6 doi: 10.1016/j.ejmg.2012.02.010. PMID: 22450339
Green L, Lesser D
South Med J 2006 Jun;99(6):617-9. doi: 10.1097/01.smj.0000217212.73359.e7. PMID: 16800419

Therapy

Ni X, Jin C, Jiang Y, Wang O, Li M, Xing X, Xia W
BMC Med Genet 2020 Oct 31;21(1):214. doi: 10.1186/s12881-020-01154-3. PMID: 33129265Free PMC Article

Prognosis

Schirwani S, Metcalfe K, Wagner B, Berry I, Sobey G, Jewell R
Eur J Med Genet 2020 Apr;63(4):103798. Epub 2019 Oct 23 doi: 10.1016/j.ejmg.2019.103798. PMID: 31655143
Chang KY, Tho KS, Khong KS
Ann Acad Med Singap 1997 Jul;26(4):453-5. PMID: 9395809

Clinical prediction guides

Duzenli T, Sezer A, Kayhan G, Arslan AT, Percin FE
Am J Med Genet A 2023 Aug;191(8):2232-2239. Epub 2023 May 23 doi: 10.1002/ajmg.a.63300. PMID: 37218527
Schirwani S, Metcalfe K, Wagner B, Berry I, Sobey G, Jewell R
Eur J Med Genet 2020 Apr;63(4):103798. Epub 2019 Oct 23 doi: 10.1016/j.ejmg.2019.103798. PMID: 31655143
Colombi M, Dordoni C, Venturini M, Ciaccio C, Morlino S, Chiarelli N, Zanca A, Calzavara-Pinton P, Zoppi N, Castori M, Ritelli M
Clin Genet 2017 Dec;92(6):624-631. Epub 2017 Sep 4 doi: 10.1111/cge.13052. PMID: 28485813
Chang KY, Tho KS, Khong KS
Ann Acad Med Singap 1997 Jul;26(4):453-5. PMID: 9395809

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...